Brief: Karuna Therapeutics Reports First Quarter 2022 Financial Results And Provides General Business Update
05/05/2022 12:25
May 5 (Reuters) - Karuna Therapeutics Inc KRTX.O :
* KARUNA THERAPEUTICS REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS
AND PROVIDES GENERAL BUSINESS UPDATE
* KARUNA - $443.2 MILLION IN CASH EXPECTED TO FUND
OPERATIONS FOR
AT LEAST 12 MONTHS FOLLOWING POTENTIAL NDA SUBMISSION OF KARXT
FOR SCHIZOPHRENIA
* QTRLY LOSS PER SHARE 1.95
* Q1 EARNINGS PER SHARE VIEW $-2.11 -- REFINITIV IBES DATA
Source text for Eikon: ID:nBw9pCTYta
Further company coverage: KRTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Karuna Therapeutics
See all newsMoody's says pharma outlook turns 'positive' on GLP-1 drug push
Brief: Karuna Therapeutics Says Complaint Was Filed By Karuna Stockholder Seeking To Enjoin Proposed Merger With Bristol-Myers Squibb
Karuna Therapeutics Inc reports results for the quarter ended in December - Earnings Summary
Karuna Therapeutics Inc expected to post a loss of $2.65 a share - Earnings Preview
Bristol Myers posts better-than-expected 4th-quarter results (updated)